$63.3 Thousand is the total value of Telemetry Investments, L.L.C.'s 146 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QQQ | New | INVESCO QQQ TRput | $7,988 | – | 30,000 | +100.0% | 12.62% | – |
| BKLN | New | INVESCO EXCH TRADED FD TR IIput | $1,026 | – | 50,000 | +100.0% | 1.62% | – |
| STOR | New | STORE CAP CORP | $1,009 | – | 31,461 | +100.0% | 1.59% | – |
| New | IMAGO BIOSCIENCES INC | $694 | – | 19,291 | +100.0% | 1.10% | – | |
| ATCO | New | ATLAS CORPshares | $625 | – | 40,755 | +100.0% | 0.99% | – |
| POSH | New | POSHMARK INC | $567 | – | 31,701 | +100.0% | 0.90% | – |
| EVOP | New | EVO PMTS INC | $558 | – | 16,500 | +100.0% | 0.88% | – |
| IRBT | New | IROBOT CORP | $449 | – | 9,332 | +100.0% | 0.71% | – |
| ESPR | New | ESPERION THERAPEUTICS INC NE | $442 | – | 71,000 | +100.0% | 0.70% | – |
| ASRT | New | ASSERTIO HOLDINGS INC | $430 | – | 100,000 | +100.0% | 0.68% | – |
| UMPQ | New | UMPQUA HLDGS CORP | $363 | – | 20,363 | +100.0% | 0.57% | – |
| GRTS | New | GRITSTONE BIO INC | $362 | – | 105,000 | +100.0% | 0.57% | – |
| ACI | New | ALBERTSONS COS INC | $311 | – | 15,000 | +100.0% | 0.49% | – |
| PRTA | New | PROTHENA CORP PLC | $301 | – | 5,000 | +100.0% | 0.48% | – |
| ONEM | New | 1LIFE HEALTHCARE INC | $294 | – | 17,600 | +100.0% | 0.46% | – |
| BNFT | New | BENEFITFOCUS INC | $283 | – | 27,100 | +100.0% | 0.45% | – |
| New | BABYLON HLDGS LTD | $267 | – | 39,500 | +100.0% | 0.42% | – | |
| RAPT | New | RAPT THERAPEUTICS INC | $238 | – | 12,000 | +100.0% | 0.38% | – |
| PLD | New | PROLOGIS INC. | $237 | – | 2,100 | +100.0% | 0.37% | – |
| EURN | New | EURONAV NV | $228 | – | 13,405 | +100.0% | 0.36% | – |
| BIIB | New | BIOGEN INC | $226 | – | 817 | +100.0% | 0.36% | – |
| New | RIVIAN AUTOMOTIVE INC | $209 | – | 11,345 | +100.0% | 0.33% | – | |
| SQ | New | BLOCK INCcl a | $207 | – | 3,302 | +100.0% | 0.33% | – |
| ARDX | New | ARDELYX INC | $191 | – | 67,000 | +100.0% | 0.30% | – |
| NVAX | New | NOVAVAX INC | $181 | – | 17,632 | +100.0% | 0.29% | – |
| AMPY | New | AMPLIFY ENERGY CORP NEW | $181 | – | 20,600 | +100.0% | 0.29% | – |
| New | USERTESTING INC | $180 | – | 24,000 | +100.0% | 0.28% | – | |
| CNK | New | CINEMARK HLDGS INC | $171 | – | 19,713 | +100.0% | 0.27% | – |
| GPS | New | GAP INC | $153 | – | 13,593 | +100.0% | 0.24% | – |
| APP | New | APPLOVIN CORP | $139 | – | 13,210 | +100.0% | 0.22% | – |
| New | DIGITALBRIDGE GROUP INCcl a new | $133 | – | 12,161 | +100.0% | 0.21% | – | |
| PTON | New | PELOTON INTERACTIVE INC | $130 | – | 16,366 | +100.0% | 0.20% | – |
| EC | New | ECOPETROL S Asponsored ads | $118 | – | 11,254 | +100.0% | 0.19% | – |
| ACOR | New | ACORDA THERAPEUTICS INC | $102 | – | 132,500 | +100.0% | 0.16% | – |
| UMC | New | UNITED MICROELECTRONICS CORPspon adr new | $81 | – | 12,330 | +100.0% | 0.13% | – |
| AGFS | New | AGROFRESH SOLUTIONS INC | $75 | – | 25,201 | +100.0% | 0.12% | – |
| ELVT | New | ELEVATE CREDIT INC | $69 | – | 39,373 | +100.0% | 0.11% | – |
| HARP | New | HARPOON THERAPEUTICS INC | $67 | – | 93,000 | +100.0% | 0.11% | – |
| New | APTOSE BIOSCIENCES INC | $58 | – | 100,000 | +100.0% | 0.09% | – | |
| New | CHECKPOINT THERAPEUTICS INC | $51 | – | 10,000 | +100.0% | 0.08% | – | |
| New | MARIADB PLC | $48 | – | 12,000 | +100.0% | 0.08% | – | |
| FBIO | New | FORTRESS BIOTECH INC | $47 | – | 72,000 | +100.0% | 0.07% | – |
| New | ECARX HOLDINGS INC*w exp 12/20/202 | $14 | – | 144,769 | +100.0% | 0.02% | – | |
| New | MARIADB PLC*w exp 12/16/202 | $10 | – | 34,432 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| RIGEL PHARMACEUTICALS INC | 33 | Q4 2022 | 1.7% |
| AFFIMED N V | 31 | Q4 2022 | 3.9% |
| GLOBALSTAR INC | 30 | Q4 2022 | 2.5% |
| VIEWRAY INC | 23 | Q4 2022 | 2.1% |
| SPDR GOLD TRUST | 22 | Q4 2022 | 2.3% |
| ADMA BIOLOGICS INC | 21 | Q4 2022 | 2.9% |
| STEMLINE THERAPEUTICS INC | 21 | Q1 2020 | 1.2% |
| SPDR S&P 500 ETF TR | 20 | Q4 2022 | 53.9% |
| KADMON HLDGS INC | 19 | Q2 2021 | 7.0% |
| EIGER BIOPHARMACEUTICALS INC | 19 | Q4 2022 | 6.7% |
View Telemetry Investments, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Xtant Medical Holdings, Inc. | February 13, 2020 | 752,915 | 5.7% |
| Orexigen Therapeutics, Inc. | February 14, 2019 | 1,295,844 | 6.4% |
| Xtant Medical Holdings, Inc. | February 14, 2018 | 1,416,339 | 7.2% |
View Telemetry Investments, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-17 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
View Telemetry Investments, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.